Alteogen executives celebrate shareholder approval for KOSPI listing outside Korea Exchange building, with rising stock charts.
AIによって生成された画像

Major bio firm Alteogen seeks KOSPI listing

AIによるレポート AIによって生成された画像

Alteogen, the top market cap company on South Korea's secondary KOSDAQ market, has decided to move to the main KOSPI bourse to secure stable funding and enhance its corporate value. Shareholders approved the proposal on Monday, with the firm aiming for a listing next year.

Korea's main bourse operator, the Korea Exchange (KRX), announced Thursday various plans to strengthen its substantive review for delisting to expedite the exit of troubled companies. The move aligns with the government's efforts to revamp the smaller, venture-heavy KOSDAQ into something resembling the Nasdaq in the United States.

このウェブサイトはCookieを使用します

サイトを改善するための分析にCookieを使用します。詳細については、プライバシーポリシーをお読みください。
拒否